Visit our news and blog page to keep up to date with our insights and the latest developments in science, policy and health.
2026
- Polygenic scores and public health services: moving the debate forward
- Genomics, medicine and population health to 2050
2025
- Precision health in a changing climate
- The changing nature of diagnosis: implications for policy, practice and patients
- Synthetic data for development of AI as a medical device (AIaMDs)
- Optimising EXome PREnatal Sequencing Services (EXPRESS)
2024
- Familial genomic information (goes to external website)
- Host genomics: lessons for infectious disease
2023
- Heat, health and human genetics
- Human involvement in AI-driven digital pathology pathways: ethical and legal considerations
- Workshop report on adopting a risk tool for stratification and predictive prevention of oesophageal cancer
- Are synthetic health data ‘personal data’?
- Evaluation of polygenic score applications
2022
2021
- Control of patient information in the COVID-19 era
- Implementing polygenic scores for cardiovascular disease into NHS Health Checks
- The ethical and legal framework for a Genomics England and Sano Genetics participant engagement platform
- Polygenic scores and clinical utility
- Visual identifiers in the care of people with dementia
2020
- Citizen generated data and health: predictive prevention of disease
- Personalising breast cancer prevention – bridging the gap between research and policy
- The GDPR and genomic data
- Artificial intelligence for genomic medicine
- Black box medicine and transparency
2019
- Our healthy future – a series of reports incl.
- Algorithms as medical devices
- Regulating algorithms in healthcare: the GDPR and IVDR in practice
- Polygenic scores, risk and cardiovascular disease
- Personalising prevention for breast cancer
- Dementia risk prediction
2018
- The personalised medicine technology landscape
- Genomics in mainstream clinical pathways
- Identification and genomic data
2017
- Personalised prevention in breast cancer – the policy landscape
- Developing effective ctDNA testing services for lung cancer
- Linking and sharing routine health data for research
- Variant classification and interpretation – workshop report
- Whole exome sequencing in clinical genetics – a health economic evaluation
- Personalised healthcare: bringing the future into focus
- Delivering improved access to genetic testing in epithelial ovarian cancer
2016
2015
- Data sharing to support UK clinical genetics and genomics services
- Pathogen genomics into practice
- Genetic screening programmes: an international review of assessment criteria
2014
- Realising genomics in clinical practice
- A guide to the investigation of intellectual disability and developmental delay in East Anglia
- Enhanced Genetic Services Project
- Stratified screening for cancer
2013
- Realising genomics in clinical practice (interim report)
- Managing incidental and pertinent findings from WGS in the 100,000 Genomes Project
- Genomics of obesity
2012
2011
- Epidemiology, risk and causation
- Next steps in the sequence
- Quality standards in risk prediction
- Genetics and mainstream medicine: service development and integration
2010
- Public health in an era of genome-based and personalised medicine
- Expanded newborn screening
- Independent response to House of Lords Science and Technology Committee Genomic Medicine report
- Predicting the risk of coronary heart disease with conventional, genetic and novel molecular biomarkers
2009
- Tay Sachs Disease carrier screening in the Ashkenazi Jewish population
- Heart to Heart: inherited cardiovascular conditions services
- Cell-free fetal nucleic acids for non-invasive prenatal diagnosis
2008
- Evidence and evaluation: Building public trust in genetic tests for common diseases
- Genetic ophthalmology in focus
- The evaluation of diagnostic laboratory tests and complex biomarkers
2007
- The evaluation of clinical validity and clinical utility of genetic tests
- Family history as a risk factor for common, complex disease
- Moving beyond ACCE: An expanded framework for genetic test evaluation
2006
- Assessment of the Human Tissue Act
- Evaluation of array-CGH for chromosomal abnormalities in clinical practice
- Learning disability: the interface with genetics
- Biomarkers in familial colorectal cancer screening
- Ethical legal and social issues in stem cell research and therapy – 2nd edition
2005
2004
2003
2001
2000
2025
- The changing nature of diagnosis: background briefing
- AI-driven multiomics in health: our 2025 roundtable insights
- Gene therapy and type 1 diabetes
- Geroscience: reframing ageing research
2024
- Infection and autoimmune disease
- Pathomics, genomics and AI in cancer care
- Regulating Advanced Therapy Medicinal Products in the UK after Brexit
- Electrogenetics – a new avenue in precision medicine
- The federation of trusted research environments for genomics and health
- DNA as data storage
2023
- Optical genome mapping
- Non-coding variants and transcripts for rare disease diagnostics
- Unpacking polygenic scores – a series of policy briefings incl:
- The European Health Data Space
- Host genomics for better infectious disease treatment
2022
- Gene editing animals for organ transplants to humans
- Long-read sequencing: Clinical applications and implementation
- Clinical long-read sequencing
- Precision medicine for inflammatory bowel disease
- Data intermediaries for health
- CAR-T cell therapies
2021
- Phage therapy to treat AMR infections
- Antisense oligonucleotide therapies
- Age-related macular degeneration and genomics
2020
- Functional genomics
- Functional genomics in clinical medicine
- Unpicking the impact of the GDPR on genomic data
- Putting AI to work in genomic medicine
- Black box medicine and transparency
2019
- Somatic genome editing: ethics and regulation
- Somatic genome editing: promise and practicalities
- Citizen generated data – an opportunity for public health?
- Somatic genome editing: an overview
- Citizen generated data: the ethics of remote patient monitoring
- What is an algorithm?
2018
- What is long read sequencing?
- RNA vaccines: an introduction
- Long read sequencing: Ready for the clinic?
- Legal liability for machine learning in healthcare
- What is citizen generated data?
- What is the GDPR?
- What is the IVDR?
2017
- Linking and sharing routine health data for research in England
- ctDNA technology in lung cancer: personalised healthcare in action
2016
- Circulating tumour DNA technology: the future of cancer management?
- Delivering an effective infectious disease genomics service
2015
- Protecting patients from healthcare associated infections: a role for genomics
- Genomics for infection control: meeting local and national needs
- Phenotyping patients for genomic diagnostics
- One health genomics – why animal diseases matter for human health
2014
- Genomics and the management of antimicrobial resistance: current successes and future challenges
- Array CGH testing for learning disability- when is it worth it?
- Sharing clinical genomic data for better diagnostics
- Leading the way: driving the delivery of pathogen genomics into practice
- Setting the right standards for clinical genome analysis
- The impact of genomic sequencing technologies on patient pathways
- Defining the role of a bioinformatician
- Beating the bugs: the pathogen genomics revolution
- Genomics and the boundary between research and clinical care and treatment
- The genomic contribution to diabetes
- Clinical whole genome analysis: delivering the right diagnosis
- ELSI and the implemention of WGS/WES in clinical practice
2026
2025
- AI-driven multiomics in health
- Precision health in a changing climate
- Personalised health: treating the person
- Host genomics: lessons for infectious diseases
- Genome editing: a lot to think about
- Electrogenetics: another tool for precision medicine?
- A look at gene therapy for type 1 diabetes
- Digital twins for health care and research
- Phages: a virus on our side?
- Can long-read sequencing transform genetic diagnosis?
- Polygenic scores – one size does not fit all
- Gene editing animals for organ transplants to humans
- Precision medicine for inflammatory bowel disease
- Liquid biopsies for cancer
2022
2021
- Clinical utility
- Host genomics and infectious disease
- Nutritional genomics
- Pharmacogenomics
- Stem cell therapies
- Vaccinomics
2020
A complete list of our published academic papers can be found on the journal papers page or you can view on their respective author pages.